Harvard Medical School Q-FASTR
Supports the United States Harvard Medical School affiliated faculty with internal seed funding and University-owned commercialization pathways.
United Statesqfastr.hms.harvard.edu
Annual funding—
Programs1
Active grants0
Total grants2
About
Q-FASTR, the Quadrangle Fund for Advancing and Seeding Translational Research at Harvard Medical School, is an internal seed fund for early-stage therapeutics. It is administered by the HMS Innovation Hub under the Office of the Dean and is reserved for Harvard Medical School Quadrangle faculty and closely related Harvard investigators working under Harvard IP arrangements.
The fund backs commerc…